| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |